Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
29/11/2023 17:28
Nov 29 (Reuters) - Ceapro Inc CZO.V :
* CEAPRO INC. REPORTS 2023 THIRD QUARTER AND NINE-MONTH
FINANCIAL
RESULTS AND OPERATIONAL HIGHLIGHTS
* CEAPRO INC: Q3 2023 SALES OF $2.6 MILLION VERSUS $3.8
MILLION
* CEAPRO INC: QTRLY LOSS PER SHARE $0.01
Source text for Eikon: ID:nGNX60DTK6
Further company coverage: CZO.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ceapro
See all newsBrief: Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
Brief: Ceapro Receives Final Court Approval For Merger With Aeterna Zentaris
Brief: Aeterna Zentaris And Ceapro Announce Merger Of Equals To Create Diversified Biopharmaceutical Company
Brief: Ceapro Inc. Reports 2023 Third Quarter And Nine-Month Financial Results And Operational Highlights
Brief: Ceapro Initiates Phase 1-2A Study Assessing Avenanthramides For Potential Applications In Inflammation Based Diseases